United In ALS research and care.
ALS ONE is an unprecedented partnership of ALS researchers, clinicians, and care providers who have joined forces to advance critical research towards a cure while simultaneously providing essential equipment and resources to individuals currently living with the disease.
Working together and funding research for a cure tomorrow while providing equipment and resources to individuals living with ALS today.
Working together
With the strength of the most caring community, we advance research towards treatments leading to an ultimate cure for ALS while providing equipment and resources to individuals living with the disease now in order to ensure the very best support, access to treatment, and quality of life for them during their journey with the currently 100% terminal disease.
ALS Research Publication Review Series
REVIEW 3: “Longitudinal Biomarkers in Amyotrophic Lateral Sclerosis.”
Our 1st review of two under the umbrella of ALS Biomarkers, aired on August 27, 2024, spotlighting the publication entitled, “Longitudinal Biomarkers in Amyotrophic Lateral Sclerosis.” We were honored to be joined by two of the authors, Dr. James Berry, MD, MPH, Director of the MGH ALS clinic and Chief of the Division of ALS & MND at MGH, and Dr. Robert Bowser, PhD, Chief Scientific Officer at Barrow Neurological Institute. Joining our Executive Director, Jennifer DiMartino on the panel for this review, is Dr. Stephen Johnson, Neurologist at Mayo Clinic & NEALS NICE Committee Member. Jean Swidler, Founder & Exec. Dir of End the Legacy, and NEALS Research Ambassador; and Lori Larson Heller, NEALS Research Ambassador & PAC Member. We hope you enjoy the webinar and we thank all who so generously participated to help the ALS community.
👓 We also invite you to read the publication by going to: https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.51078